Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
2008 1
2011 2
2012 1
2014 1
2017 1
2018 4
2020 1
2021 3
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Did you mean m r daha (22 results)?
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer.
Shaw AT, Bauer TM, de Marinis F, Felip E, Goto Y, Liu G, Mazieres J, Kim DW, Mok T, Polli A, Thurm H, Calella AM, Peltz G, Solomon BJ; CROWN Trial Investigators. Shaw AT, et al. N Engl J Med. 2020 Nov 19;383(21):2018-2029. doi: 10.1056/NEJMoa2027187. N Engl J Med. 2020. PMID: 33207094 Clinical Trial.
Whole-genome sequencing reveals host factors underlying critical COVID-19.
Kousathanas A, Pairo-Castineira E, Rawlik K, Stuckey A, Odhams CA, Walker S, Russell CD, Malinauskas T, Wu Y, Millar J, Shen X, Elliott KS, Griffiths F, Oosthuyzen W, Morrice K, Keating S, Wang B, Rhodes D, Klaric L, Zechner M, Parkinson N, Siddiq A, Goddard P, Donovan S, Maslove D, Nichol A, Semple MG, Zainy T, Maleady-Crowe F, Todd L, Salehi S, Knight J, Elgar G, Chan G, Arumugam P, Patch C, Rendon A, Bentley D, Kingsley C, Kosmicki JA, Horowitz JE, Baras A, Abecasis GR, Ferreira MAR, Justice A, Mirshahi T, Oetjens M, Rader DJ, Ritchie MD, Verma A, Fowler TA, Shankar-Hari M, Summers C, Hinds C, Horby P, Ling L, McAuley D, Montgomery H, Openshaw PJM, Elliott P, Walsh T, Tenesa A; GenOMICC investigators; 23andMe investigators; COVID-19 Human Genetics Initiative; Fawkes A, Murphy L, Rowan K, Ponting CP, Vitart V, Wilson JF, Yang J, Bretherick AD, Scott RH, Hendry SC, Moutsianas L, Law A, Caulfield MJ, Baillie JK. Kousathanas A, et al. Nature. 2022 Jul;607(7917):97-103. doi: 10.1038/s41586-022-04576-6. Epub 2022 Mar 7. Nature. 2022. PMID: 35255492 Free PMC article.
First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1.
Nishio M, Ohe Y, Ikeda S, Yokoyama T, Hayashi H, Fukuhara T, Sato Y, Tanaka H, Hotta K, Sugawara S, Daga H, Okamoto I, Kasahara K, Naito T, Li L, Gupta RG, Bushong J, Mizutani H. Nishio M, et al. Int J Clin Oncol. 2023 Oct;28(10):1354-1368. doi: 10.1007/s10147-023-02390-2. Epub 2023 Aug 7. Int J Clin Oncol. 2023. PMID: 37548831 Free PMC article. Clinical Trial.
Overexpression and biochemical characterization of DagA from Streptomyces coelicolor A3(2): an endo-type beta-agarase producing neoagarotetraose and neoagarohexaose.
Temuujin U, Chi WJ, Lee SY, Chang YK, Hong SK. Temuujin U, et al. Appl Microbiol Biotechnol. 2011 Nov;92(4):749-59. doi: 10.1007/s00253-011-3347-7. Epub 2011 Jun 8. Appl Microbiol Biotechnol. 2011. PMID: 21655986
To develop an improved expression system for dagA, three types of strong promoters for the Streptomyces host were linked to dagA, and their efficiencies in DagA production were compared in S. lividans TK24. ...The K(m), V(max), and K(cat) …
To develop an improved expression system for dagA, three types of strong promoters for the Streptomyces host were linked to dagA …
Transport systems for alanine, serine, and glycine in Escherichia coli K-12.
Robbins JC, Oxender DL. Robbins JC, et al. J Bacteriol. 1973 Oct;116(1):12-8. doi: 10.1128/jb.116.1.12-18.1973. J Bacteriol. 1973. PMID: 4583203 Free PMC article.
Reciprocal plots for l-alanine entry are distinctly biphasic, giving rise to K(m) values of about 2 and 27 muM. The major route of glycine entry can be described by a single K(m) value of about 4 muM. A higher K(m) value for glycine of ar …
Reciprocal plots for l-alanine entry are distinctly biphasic, giving rise to K(m) values of about 2 and 27 muM. The major rout …
Preventing visual field deficits from neurosurgery.
Winston GP, Daga P, White MJ, Micallef C, Miserocchi A, Mancini L, Modat M, Stretton J, Sidhu MK, Symms MR, Lythgoe DJ, Thornton J, Yousry TA, Ourselin S, Duncan JS, McEvoy AW. Winston GP, et al. Neurology. 2014 Aug 12;83(7):604-11. doi: 10.1212/WNL.0000000000000685. Epub 2014 Jul 11. Neurology. 2014. PMID: 25015363 Free PMC article.
Direct quantitative measurement of the kinetics of HLA-specific antibody interactions with isolated HLA proteins.
Daga S, Moyse H, Briggs D, Lowe D, Evans N, Jones J, Buchli R, McMurtrey C, Mulder A, Hildebrand W, Claas F, Higgins R, Mitchell DA, Zehnder D. Daga S, et al. Hum Immunol. 2018 Feb;79(2):122-128. doi: 10.1016/j.humimm.2017.10.012. Epub 2017 Oct 31. Hum Immunol. 2018. PMID: 29097266
All antibodies were characterized by fast on-rates and slow off rates but with a wide range of association rates (k(on,) 3.63-24.25 10(5) per mol per second) and dissociation rates (k(off), 0.99-10.93 10(-3) per second). Dissociation constants (K(D)) ranged f …
All antibodies were characterized by fast on-rates and slow off rates but with a wide range of association rates (k(on,) 3.63-24.25 1 …
A randomized study of the safety and pharmacokinetics of GSK3358699, a mononuclear myeloid-targeted bromodomain and extra-terminal domain inhibitor.
Brown JA, Bal J, Simeoni M, Williams P, Mander PK, Soden PE, Daga S, Fahy WA, Wong GK, Bloomer JC, Erwig L, Cui Y, Fernando D, Carnaghan H, Banham-Hall EJ, Hopkins S, Davis BG, Oliveira JJD, Prinjha RK. Brown JA, et al. Br J Clin Pharmacol. 2022 May;88(5):2140-2155. doi: 10.1111/bcp.15137. Epub 2021 Dec 18. Br J Clin Pharmacol. 2022. PMID: 34773923 Free PMC article. Clinical Trial.
Identification and biochemical characterization of Sco3487 from Streptomyces coelicolor A3(2), an exo- and endo-type β-agarase-producing neoagarobiose.
Temuujin U, Chi WJ, Chang YK, Hong SK. Temuujin U, et al. J Bacteriol. 2012 Jan;194(1):142-9. doi: 10.1128/JB.05978-11. Epub 2011 Oct 21. J Bacteriol. 2012. PMID: 22020647 Free PMC article.
To constitute a crucial carbon source for bacterial growth, the alternating alpha-(1,3) and beta-(1,4) linkages between the 3,6-anhydro-L-galactoses and D-galactoses of agar must be hydrolyzed by alpha/beta-agarases. In S. coelicolor, DagA was confirmed to be an endo-type …
To constitute a crucial carbon source for bacterial growth, the alternating alpha-(1,3) and beta-(1,4) linkages between the 3,6-anhydro-L-ga …
Sequential therapy of crizotinib followed by alectinib for non-small cell lung cancer harbouring anaplastic lymphoma kinase rearrangement (WJOG9516L): A multicenter retrospective cohort study.
Ito K, Yamanaka T, Hayashi H, Hattori Y, Nishino K, Kobayashi H, Oya Y, Yokoyama T, Seto T, Azuma K, Fukui T, Kozuki T, Nakamura A, Tanaka K, Hirano K, Yokoi T, Daga H, Sakata S, Fujimoto D, Mori M, Maeno K, Aoki T, Tamura A, Miura S, Watanabe S, Akamatsu H, Hataji O, Suzuki K, Hontsu S, Azuma K, Bessho A, Kubo A, Okuno M, Nakagawa K, Yamamoto N. Ito K, et al. Eur J Cancer. 2021 Mar;145:183-193. doi: 10.1016/j.ejca.2020.12.026. Epub 2021 Jan 22. Eur J Cancer. 2021. PMID: 33486442
15 results